Form 4 for MRK Merck & Co.
Accepted 2023-08-04 00:00:00 ET · period of report 2023-08-03 · accession 0001127602-23-022015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-04 | 2023-08-03 | MRK | Guindo Chirfi | CMO | M - OptEx | $105.70 | +36.9K | 38.3K | +2,561% | +$3.90M |
| D | 2023-08-04 | 2023-08-03 | MRK | Guindo Chirfi | CMO | F - Tax | $105.70 | -18.0K | 20.4K | -47% | -$1.90M |
| D | 2023-08-04 | 2023-08-03 | MRK | Guindo Chirfi | CMO | M - OptEx | $0.00 | -36.9K | 73.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-03 | M | A | 36,901 | $105.70 | 38,341.68 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 2 | Common | Common Stock | 2023-08-03 | F | D | 17,989 | $105.70 | 20,352.68 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-08-03 | M | D | 36,901 | $0.00 | 73,804 | D | — · 2023-08-03 to 2025-08-03 | 36,901 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F4) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025. |